NEU neuren pharmaceuticals limited

Ann: Plans for Phase 3 trial in Rett syndrome, page-93

  1. 2,562 Posts.
    lightbulb Created with Sketch. 2667
    Cuppa .I think the management of Neuren  is very good ,however I think Torreya appointment is very good as their network around the world is extraordinary.The appointment tells me we are open to a serious offer for the business .So game is on .I think the market thinks that too!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.92
Change
0.070(0.54%)
Mkt cap ! $1.626B
Open High Low Value Volume
$13.15 $13.37 $12.85 $6.608M 504.7K

Buyers (Bids)

No. Vol. Price($)
2 556 $12.90
 

Sellers (Offers)

Price($) Vol. No.
$12.92 1094 6
View Market Depth
Last trade - 15.40pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.